Article Versions Notes

Di Pierro F, Ficuccilli F, Tessieri L, Menasci F, Pasquale C, Khan A, Rabbani F, Memon NM, Cazzaniga M, Bertuccioli A, et al. Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study. Microorganisms. 2025; 13(5):1139. https://doi.org/10.3390/microorganisms13051139

Di Pierro, Francesco, Fabrizio Ficuccilli, Laura Tessieri, Francesca Menasci, Chiara Pasquale, Amjad Khan, Fazle Rabbani, Nazia Mumtaz Memon, Massimiliano Cazzaniga, Alexander Bertuccioli, and et al. 2025. "Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study" Microorganisms 13, no. 5: 1139. https://doi.org/10.3390/microorganisms13051139

Di Pierro, F., Ficuccilli, F., Tessieri, L., Menasci, F., Pasquale, C., Khan, A., Rabbani, F., Memon, N. M., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., Recchia, M., Palazzi, C. M., Tanda, M. L., & Zerbinati, N. (2025). Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study. Microorganisms, 13(5), 1139. https://doi.org/10.3390/microorganisms13051139